Koninklijke Philips NV

NL

PHG

Health Care

20.61 ₽

Current price

Sell
20.61 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    360 / 663

  • Position in country

    173 / 223

  • Net income margin, %

    0.7

    -12.5

  • EBITDA margin, %

    27.6

    -2.5

  • Debt to Equity, %

    63.9

    15

  • Intangible assets and goodwill, %

    44.4

    3.9

  • Revenue CAGR 3Y, %

    1.6

    12.6

  • Total Equity change 1Y, %

    -6.4

    0

  • Revenue Y, % chg

    5.1

    4.6

  • P/BV

    1.4

    1.7

  • P/S

    0.9

    3.7

  • EV/S

    1.2

    3.2

  • EV/EBITDA

    6.8

    -0.2

  • Average Analyst recommendation

    Sell

    Sell

  • Average upside forecasts, %

    6.6

    66.5

  • Forward P/E

    13.4

    19.2

  • Forward Dividend Yield, %

    4.4

    0.2

  • Expected dividend per share

    0.8

    0

  • Dividend Ex Date

    2024-05-09

Get an analytical review of this company

Competitors

Ranks

  • Dexcom Inc

    00%

  • Boston Scientific Corp

    00%

  • Intuitive Surgical Inc

    00%

  • Stryker Corp

    00%

  • Medtronic PLC

    00%

  • Edwards Lifesciences Corp

    00%

  • Siemens Healthineers AG

    00%

  • Abbott Laboratories

    00%

  • Koninklijke Philips NV

    00%

  • Becton Dickinson and Co

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Netherlands

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    18726

  • Ticker

    PHG.N

  • ISIN

    US5004723038

  • IPO date

    2009-09-18

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-02-20

  • Date fact. publication of reports

    2023-12-31

Company Description

Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care & Health Informatics businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The HealthTech Other segment comprises such items, as innovation, emerging businesses, royalties, among others. The Legacy Items segment consists mainly of separation costs, legacy legal items, legacy pension costs, among others.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: